EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusion: report of two cases with different clinical presentation

Elisabetta Merenda, Katia Paciaroni, Emilia Scalzulli, Massimo Breccia, Stefano Licci, Luisa Bizzoni, Carla Giordano, Emma Rullo

Pathologica · 2025-05 · 117 (2) · 156-161

DOI: 10.32074/1591-951x-975 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pathologica, 2025-05. Verfasst von Elisabetta Merenda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiologic, Oncologic and Pathologic Sciences, Sapienza University of Rome, Italy. Hauptthemen laut MEDLINE: Eosinophilia, Gene Fusion, Myeloproliferative Disorders, Oncogene Proteins, Fusion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (M/LN-eo-TK) such as PDGFRA, PDGFRB, FGFR1, JAK2, FLT3 rearrangement and ETV6::ABL1 fusion include rare and heterogeneous clinical-pathological entities with some similarities, not always associated with peripheral eosinophilia. Accurate diagnosis and demonstration of the specific genetic substrate have important implications since target therapy is possibly available. Herein we report two cases showing different bone marrow features and clinical presentation. Recognition of eosinophilic granuloblasts prompted genetic analysis that showed PDGFRB (case 1) and PDGFRA (case 2) gene rearrangement. Diagnosis of M/LN-eo-TK may be challenging. Pathologists may be the first professionals to suspect the disorder and should be aware of the therapeutic implication. Accurate BOM marrow evaluation with a panel of immunohistochemical reactions, and specific molecular analyses are required for proper diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EosinophiliaGene FusionMyeloproliferative DisordersOncogene Proteins, FusionProtein-Tyrosine KinasesHumansGene RearrangementReceptor, Platelet-Derived Growth Factor alphaReceptor, Platelet-Derived Growth Factor beta

Stichwörter der Autor:innen

HypereosinophiliaMyeloid/lymphoid neoplasmsPDGFRAPDGFRBTKI

Substanzen

Oncogene Proteins, FusionPDGFRB protein, humanProtein-Tyrosine KinasesReceptor, Platelet-Derived Growth Factor alphaReceptor, Platelet-Derived Growth Factor beta

Autor:innen und Institutionen

  • Department of Radiologic, Oncologic and Pathologic Sciences, Sapienza University of Rome, Italy.
  • Hematology Unit, San Filippo Hospital, Rome Italy.
  • Department of Cellular Biotechnology and Hematology BCE, Sapienza University of Rome, Italy.
  • Pathology Unit, San Filippo Hospital, Rome Italy.
  • Department of Translational and Precision Medicine, Sapienza University of Rome, Italy.

Zitieren

APA

Merenda, E., Paciaroni, K., Scalzulli, E., Breccia, M., Licci, S., Bizzoni, L., Giordano, C., & Rullo, E. (2025). Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusion: report of two cases with different clinical presentation. Pathologica, 117(2), 156-161. https://doi.org/10.32074/1591-951x-975

Vancouver

Merenda E, Paciaroni K, Scalzulli E, Breccia M, Licci S, Bizzoni L, et al. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusion: report of two cases with different clinical presentation. Pathologica. 2025;117(2):156-161. doi:10.32074/1591-951x-975

BibTeX
@article{Merenda2025,
  author = {Merenda, Elisabetta and Paciaroni, Katia and Scalzulli, Emilia and Breccia, Massimo and Licci, Stefano and Bizzoni, Luisa and Giordano, Carla and Rullo, Emma},
  title = {Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusion: report of two cases with different clinical presentation},
  journal = {Pathologica},
  year = {2025},
  volume = {117},
  number = {2},
  pages = {156--161},
  doi = {10.32074/1591-951x-975}
}
Kostenlos starten →